You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 19, 2024

THIORIDAZINE HYDROCHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Thioridazine Hydrochloride, and when can generic versions of Thioridazine Hydrochloride launch?

Thioridazine Hydrochloride is a drug marketed by Actavis Mid Atlantic, Alpharma Us Pharms, Ani Pharms, Epic Pharma Llc, Pharm Assoc, Sandoz, Wockhardt, Chartwell Rx, Heritage Pharma Avet, Mutual Pharm, Mylan, Par Pharm, Roxane, Sun Pharm Industries, Superpharm, Watson Labs, Watson Labs Teva, and West Ward. and is included in seventy-nine NDAs.

The generic ingredient in THIORIDAZINE HYDROCHLORIDE is thioridazine hydrochloride. There are eighteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the thioridazine hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Thioridazine Hydrochloride

A generic version of THIORIDAZINE HYDROCHLORIDE was approved as thioridazine hydrochloride by MYLAN on March 15th, 1983.

  Try a Trial

Drug patent expirations by year for THIORIDAZINE HYDROCHLORIDE
Recent Clinical Trials for THIORIDAZINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Rabin Medical CenterEarly Phase 1
Rambam Health Care CampusEarly Phase 1
State University of New York at BuffaloPhase 4

See all THIORIDAZINE HYDROCHLORIDE clinical trials

Pharmacology for THIORIDAZINE HYDROCHLORIDE
Drug ClassPhenothiazine
Anatomical Therapeutic Chemical (ATC) Classes for THIORIDAZINE HYDROCHLORIDE

US Patents and Regulatory Information for THIORIDAZINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs THIORIDAZINE HYDROCHLORIDE thioridazine hydrochloride TABLET;ORAL 088284-001 Aug 25, 1983 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Mylan THIORIDAZINE HYDROCHLORIDE thioridazine hydrochloride TABLET;ORAL 088004-001 Nov 18, 1983 RX No Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Mutual Pharm THIORIDAZINE HYDROCHLORIDE thioridazine hydrochloride TABLET;ORAL 087264-001 Nov 18, 1983 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Par Pharm THIORIDAZINE HYDROCHLORIDE thioridazine hydrochloride TABLET;ORAL 089765-001 Feb 9, 1988 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.